Zimmer Biomet Issues $4.34B in Senior Notes
Ticker: ZBH · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1136869
Sentiment: neutral
Topics: debt-issuance, financing, notes
TL;DR
Zimmer Biomet just dropped $4.34B in new debt across three note series.
AI Summary
On February 6, 2025, Zimmer Biomet Holdings, Inc. filed an 8-K report detailing the issuance of three series of senior notes. These include $750 million in 3.518% notes due 2032, $1.164 billion in 1.164% notes due 2027, and $2.425 billion in 2.425% notes due 2026. The filing also includes financial statements and exhibits related to these transactions.
Why It Matters
This filing indicates Zimmer Biomet is raising significant capital through debt issuance, which could be used for various corporate purposes such as acquisitions, refinancing existing debt, or funding operations.
Risk Assessment
Risk Level: medium — Issuing a large amount of debt increases financial leverage and interest expense, which can impact profitability and financial flexibility.
Key Numbers
- $4.34B — Total Senior Notes Issued (Aggregate principal amount of the three series of notes issued by Zimmer Biomet.)
- 3.518% — Interest Rate (Interest rate for the 3.518% notes due 2032.)
- 1.164% — Interest Rate (Interest rate for the 1.164% notes due 2027.)
- 2.425% — Interest Rate (Interest rate for the 2.425% notes due 2026.)
Key Players & Entities
- ZIMMER BIOMET HOLDINGS, INC. (company) — Registrant
- February 6, 2025 (date) — Date of Report
- $750 million (dollar_amount) — Principal amount of 3.518% notes due 2032
- $1.164 billion (dollar_amount) — Principal amount of 1.164% notes due 2027
- $2.425 billion (dollar_amount) — Principal amount of 2.425% notes due 2026
FAQ
What is the total principal amount of senior notes issued by Zimmer Biomet?
Zimmer Biomet issued a total of $4.34 billion in senior notes, comprised of $750 million in 3.518% notes due 2032, $1.164 billion in 1.164% notes due 2027, and $2.425 billion in 2.425% notes due 2026.
What are the maturity dates for the newly issued senior notes?
The senior notes have maturity dates in 2032 (3.518% notes), 2027 (1.164% notes), and 2026 (2.425% notes).
What is the purpose of this 8-K filing?
This 8-K filing is to report the results of operations and financial condition, specifically detailing the issuance of senior notes and including related financial statements and exhibits.
What is the interest rate on the notes due in 2027?
The 1.164% notes due in 2027 carry an interest rate of 1.164%.
In which state is Zimmer Biomet incorporated?
Zimmer Biomet Holdings, Inc. is incorporated in Delaware.
Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-02-06 06:30:10
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value ZBH New York Stock Exchan
Filing Documents
- zbh-20250206.htm (8-K) — 54KB
- zbh-ex99_1.htm (EX-99.1) — 1832KB
- img210921253_0.jpg (GRAPHIC) — 35KB
- 0000950170-25-014972.txt ( ) — 2283KB
- zbh-20250206.xsd (EX-101.SCH) — 136KB
- zbh-20250206_htm.xml (XML) — 8KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 6, 2025, Zimmer Biomet Holdings, Inc. (the "Company") issued a press release reporting its financial results for the quarter and year ended December 31, 2024. A copy of the press release is attached as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report. The information contained in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" with the Securities and Exchange Commission for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated February 6, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 6, 2025 ZIMMER BIOMET HOLDINGS, INC. By: /s/ Chad F. Phipps Name: Chad F. Phipps Title: Senior Vice President, General Counsel and Secretary